Prostate Cancer Drug - KFDA - NewsChannel 10 / Amarillo News, Weather, Sports

Prostate Cancer Drug

There's new hope for men with advanced prostate cancer.

A high-powered vitamin combined with chemo can help prolong the lives of some of the sickest prostate cancer patients.

79-year-old, David Copeland has advanced prostate cancer.

But a combination of drugs has kept the retired dentist alive and well for four years now.

"I was told by oncologists, twice, that i had two years to live and this was several years ago." as part of the "ascent" trial,

Doctor Copeland started taking high dose vitamin D pills called DN 101

DN 101 is a highly active form of vitamin D. Patients take it along with a chemotherapy drug.

"There's compelling evidence from the laboratory that very high doses of activated

Vitamin D stops cancer cell growth and inhibit and induce cancer cell death."

Researchers say DN 101 enhances the chemotherapy.

Those in the study who took the high dose vitamin d, on average, lived at least 8 months longer than those who didn't take it.

In terms of this deadly cancer, that's a significant amount of time.

"Obviously, we would love to see it be measured in years, but it would, if confirmed, it's the biggest difference in terms of survival in this condition in the history of the research that we've been doing."

Doctor Beer thinks DN 101 could become a new building block in cancer treatment.

As for Doctor Copeland...He's beaten the odds, even over and above the average dn-101 patient, giving him time and health.

 

 

  • Health WatchMore>>

  • Trump thrusts abortion fight into crucial midterm elections

    Trump thrusts abortion fight into crucial midterm elections

    Friday, May 18 2018 12:40 AM EDT2018-05-18 04:40:58 GMT
    Monday, May 21 2018 3:03 PM EDT2018-05-21 19:03:30 GMT
    (AP Photo/Manuel Balce Ceneta, File). FILE - In this Jan. 19, 2018 file photo, President Donald Trump speaks to participants of the annual March for Life event, in the Rose Garden of the White House in Washington. The Trump administration will resurrec...(AP Photo/Manuel Balce Ceneta, File). FILE - In this Jan. 19, 2018 file photo, President Donald Trump speaks to participants of the annual March for Life event, in the Rose Garden of the White House in Washington. The Trump administration will resurrec...

    The Trump administration is resurrecting a Reagan-era rule that would ban federally funded family planning clinics from discussing abortion with women, or sharing space with abortion providers.

    The Trump administration is resurrecting a Reagan-era rule that would ban federally funded family planning clinics from discussing abortion with women, or sharing space with abortion providers.

  • Community

    Coffee Memorial Blood Drive at The Granite at Thirty Fourth

    Coffee Memorial Blood Drive at The Granite at Thirty Fourth

    Monday, May 21 2018 6:31 AM EDT2018-05-21 10:31:45 GMT

    The Granite at Thirty Fourth will be hosting a blood drive Saturday, May 19, from 2:30 p.m. to 6:30 p.m. In the wake of the school shooting in Santa Fe, Texas, Coffee Memorial Blood Center has been asked to assist the Houston area with blood donations.

    The Granite at Thirty Fourth will be hosting a blood drive Saturday, May 19, from 2:30 p.m. to 6:30 p.m. In the wake of the school shooting in Santa Fe, Texas, Coffee Memorial Blood Center has been asked to assist the Houston area with blood donations.

  • FDA approves migraine preventing drug

    FDA approves migraine preventing drug

    Saturday, May 19 2018 1:15 PM EDT2018-05-19 17:15:27 GMT
    Saturday, May 19 2018 2:47 PM EDT2018-05-19 18:47:59 GMT
    Aimovig works by blocking a genetic molecule involved in migraine attacks. The drug is expected to cost $575 a month. (Source: Norvatis/CNN)Aimovig works by blocking a genetic molecule involved in migraine attacks. The drug is expected to cost $575 a month. (Source: Norvatis/CNN)

    Aimovig works by blocking a genetic molecule involved in migraine attacks. The drug is expected to cost $575 a month.

    Aimovig works by blocking a genetic molecule involved in migraine attacks. The drug is expected to cost $575 a month.

Powered by Frankly